The pharmaceuticals, medicinal chemicals, seasonally adjusted index in Norway has dropped to 171.3, which is a decrease of 9.4 (-5.2%) since 2023 Q4.
Pharmaceuticals, medicinal chemicals, seasonally adjusted index in Norway
No matching regions
Data availability:
Regions:
82
Date range: 2005 Q1 to 2024 Q1
Points:
5,455
Measure:
Index
Similar regions to Norway
Pharmaceuticals, medicinal chemicals
Norway Pharmaceuticals, medicinal chemicals between 2005 Q1 and 2024 Q1
| Period | Pharmaceuticals, medicinal chemicals | Change |
|---|---|---|
| 2024 Q1 | 171.3 | -9.4 |
| 2023 Q4 | 180.7 | +6.6 |
| 2023 Q3 | 174.1 | -12.7 |
| 2023 Q2 | 186.8 | -9.8 |
| 2023 Q1 | 196.6 | +8.8 |
| 2022 Q4 | 187.8 | +12.8 |
| 2022 Q3 | 175.0 | +4.2 |
| 2022 Q2 | 170.8 | +16.9 |
| 2022 Q1 | 153.9 | +1.0 |
| 2021 Q4 | 152.9 | -16.2 |
| 2021 Q3 | 169.1 | +7.0 |
| 2021 Q2 | 162.1 | +0.9 |
| 2021 Q1 | 161.2 | +12.1 |
| 2020 Q4 | 149.1 | +3.3 |
| 2020 Q3 | 145.8 | +10.1 |
| 2020 Q2 | 135.7 | -39.2 |
| 2020 Q1 | 174.9 | +0.5 |
| 2019 Q4 | 174.4 | +7.4 |
| 2019 Q3 | 167.0 | -1.4 |
| 2019 Q2 | 168.4 | +12.2 |
| 2019 Q1 | 156.2 | -16.9 |
| 2018 Q4 | 173.1 | -1.3 |
| 2018 Q3 | 174.4 | +5.5 |
| 2018 Q2 | 168.9 | +8.9 |
| 2018 Q1 | 160.0 | -0.3 |
| 2017 Q4 | 160.3 | +1.9 |
| 2017 Q3 | 158.4 | -8.1 |
| 2017 Q2 | 166.5 | -48.7 |
| 2017 Q1 | 215.2 | +40.0 |
| 2016 Q4 | 175.2 | +2.1 |
| 2016 Q3 | 173.1 | +23.1 |
| 2016 Q2 | 150.0 | +33.2 |
| 2016 Q1 | 116.8 | +15.0 |
| 2015 Q4 | 101.8 | +0.2 |
| 2015 Q3 | 101.6 | +3.7 |
| 2015 Q2 | 97.9 | -0.7 |
| 2015 Q1 | 98.6 | +6.2 |
| 2014 Q4 | 92.4 | +1.1 |
| 2014 Q3 | 91.3 | +4.7 |
| 2014 Q2 | 86.6 | -1.2 |
| 2014 Q1 | 87.8 | -1.9 |
| 2013 Q4 | 89.7 | +5.5 |
| 2013 Q3 | 84.2 | -3.6 |
| 2013 Q2 | 87.8 | -0.6 |
| 2013 Q1 | 88.4 | -26.1 |
| 2012 Q4 | 114.5 | +0.9 |
| 2012 Q3 | 113.6 | -2.1 |
| 2012 Q2 | 115.7 | +39.2 |
| 2012 Q1 | 76.5 | -5.1 |
| 2011 Q4 | 81.6 | +1.8 |
| 2011 Q3 | 79.8 | -19.9 |
| 2011 Q2 | 99.7 | -5.8 |
| 2011 Q1 | 105.5 | -15.0 |
| 2010 Q4 | 120.5 | +12.9 |
| 2010 Q3 | 107.6 | +41.3 |
| 2010 Q2 | 66.3 | -9.0 |
| 2010 Q1 | 75.3 | +7.1 |
| 2009 Q4 | 68.2 | -0.5 |
| 2009 Q3 | 68.7 | +1.8 |
| 2009 Q2 | 66.9 | -8.4 |
| 2009 Q1 | 75.3 | -3.7 |
| 2008 Q4 | 79.0 | +3.0 |
| 2008 Q3 | 76.0 | -12.1 |
| 2008 Q2 | 88.1 | +5.2 |
| 2008 Q1 | 82.9 | -2.6 |
| 2007 Q4 | 85.5 | 0.0 |
| 2007 Q3 | 85.5 | -5.5 |
| 2007 Q2 | 91.0 | +13.1 |
| 2007 Q1 | 77.9 | -6.1 |
| 2006 Q4 | 84.0 | +3.8 |
| 2006 Q3 | 80.2 | +8.4 |
| 2006 Q2 | 71.8 | -4.8 |
| 2006 Q1 | 76.6 | -1.0 |
| 2005 Q4 | 77.6 | -3.9 |
| 2005 Q3 | 81.5 | +0.2 |
| 2005 Q2 | 81.3 | +2.1 |
| 2005 Q1 | 79.2 |